Literature DB >> 9781545

T-cell receptor analysis in anti-Hu associated paraneoplastic encephalomyelitis.

R Voltz1, J Dalmau, J B Posner, M R Rosenfeld.   

Abstract

OBJECTIVE: To analyze the T-cell receptor (TCR) repertoire in the inflammatory infiltrates of the nervous system and tumor of patients with anti-Hu associated paraneoplastic encephalomyelitis and sensory neuronopathy (PEM/SN).
BACKGROUND: In PEM/SN, the pathogenic role of the infiltrating T cells is speculative. TCR analysis may establish whether these lymphocytes are attracted nonspecifically by a proinflammatory environment or are driven by a specific antigen or superantigen.
METHODS: We examined frozen tissues of seven patients with PEM/SN using immunohistochemical and PCR analysis. Of 62 tissue blocks from seven patients, 19 blocks from five patients had >100 CD3+ cells per section infiltrating the nervous system or tumor. These infiltrates allowed screening of the TCR Vbeta family repertoire using a panel of 18 antibodies that recognize family-specific regions of most TCR Vbeta families against which antibodies have been generated. To distinguish between antigen-driven clonal and superantigen-driven family expansion, we extracted RNA from frozen tissue and performed reverse transcriptase (RT)-PCR analysis followed by subcloning and sequencing of the antigen-specific CDR3 region of the TCR Vbeta chain.
RESULTS: All five patients showed a limited Vbeta repertoire. An overrepresentation (>10% of total CD3+) of certain Vbeta families was identified in three patients (as high as 45% of total CD3+), which consisted mainly of CD8 + cells. CDR3 sequences obtained from one patient revealed an in situ expansion of two clones in the amygdala (one at a frequency of 57%) and four clones in the tumor.
CONCLUSION: These findings suggest that an antigen-driven oligoclonal cytotoxic T-cell response plays a role in the pathogenesis of anti-Hu associated PEM/SN.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9781545     DOI: 10.1212/wnl.51.4.1146

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  31 in total

1.  T cell response to Hu-D peptides in patients with anti-Hu syndrome.

Authors:  A Rousseau; B Benyahia; J Dalmau; F Connan; J-G Guillet; J-Y Delattre; J Choppin
Journal:  J Neurooncol       Date:  2005-02       Impact factor: 4.130

Review 2.  Paraneoplastic syndromes of the CNS.

Authors:  Josep Dalmau; Myrna R Rosenfeld
Journal:  Lancet Neurol       Date:  2008-04       Impact factor: 44.182

3.  No evidence for the presence of HuD-specific T cells in the cerebrospinal fluid of patients with Hu-associated paraneoplastic neurological syndromes.

Authors:  Janet W de Beukelaar; Johannes C Milikan; Georges M Verjans; Marieke T de Graaf; Yvette van Norden; Cor H Lamers; Martin J van den Bent; Jacoline E Bromberg; Esther Hulsenboom; Kees Sintnicolaas; Jan W Gratama; Peter A Sillevis Smitt
Journal:  J Neurol       Date:  2009-02-27       Impact factor: 4.849

4.  CD4+ and CD8+ T cells are both needed to induce paraneoplastic neurological disease in a mouse model.

Authors:  Christina Gebauer; Béatrice Pignolet; Lidia Yshii; Emilie Mauré; Jan Bauer; Roland Liblau
Journal:  Oncoimmunology       Date:  2016-12-09       Impact factor: 8.110

Review 5.  Sensory Neuronopathies.

Authors:  Allison Crowell; Kelly G Gwathmey
Journal:  Curr Neurol Neurosci Rep       Date:  2017-08-23       Impact factor: 5.081

Review 6.  Updates in the Diagnosis and Treatment of Paraneoplastic Neurologic Syndromes.

Authors:  Ronnyson Susano Grativvol; Wagner Cid Palmeira Cavalcante; Luiz Henrique Martins Castro; Ricardo Nitrini; Mateus Mistieri Simabukuro
Journal:  Curr Oncol Rep       Date:  2018-11-10       Impact factor: 5.075

7.  A new Purkinje cell antibody (anti-Ca) associated with subacute cerebellar ataxia: immunological characterization.

Authors:  Sven Jarius; Klaus P Wandinger; Sigrun Horn; Heike Heuer; Brigitte Wildemann
Journal:  J Neuroinflammation       Date:  2010-03-12       Impact factor: 8.322

8.  A prospective open-label study of sirolimus for the treatment of anti-Hu associated paraneoplastic neurological syndromes.

Authors:  Adriaan H de Jongste; Teun van Gelder; Jacoline E Bromberg; Marieke T de Graaf; Jan W Gratama; Marco W Schreurs; Herbert Hooijkaas; Peter A Sillevis Smitt
Journal:  Neuro Oncol       Date:  2014-07-03       Impact factor: 12.300

9.  Immune response in lung cancer mouse model mimics human anti-Hu reactivity.

Authors:  Meleeneh Kazarian; Joaquim Calbo; Natalie Proost; Catherine L Carpenter; Anton Berns; Ite A Laird-Offringa
Journal:  J Neuroimmunol       Date:  2009-09-17       Impact factor: 3.478

Review 10.  Encephalitis and epilepsy.

Authors:  Jan Bauer; Christian G Bien
Journal:  Semin Immunopathol       Date:  2009-09-11       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.